Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

Property Value
dbo:abstract
  • Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. (en)
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2019-11-20 00:38:13Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 42358544 (xsd:integer)
dbo:wikiPageLength
  • 11817 (xsd:integer)
dbo:wikiPageModified
  • 2019-11-20 00:38:10Z (xsd:date)
dbo:wikiPageOutDegree
  • 35 (xsd:integer)
dbo:wikiPageRevisionID
  • 927045346 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdfs:comment
  • Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. (en)
rdfs:label
  • Acceleron Pharma (en)
owl:sameAs
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of